DecisionRx, Inc. and BeneCard PBF Partner to Redefine Pharmacy Benefits Through Personalized Medication Optimization
DecisionRx, Inc., a leader in Medication Therapy Optimization (MTO), and BeneCard PBF, the original Pharmacy Benefit Facilitator (PBF), today announced a strategic partnership designed to bring personalized, data-driven medication insights to BeneCard PBF’s clients and members nationwide.
DecisionRx and Beanstalk Benefits Join Forces to Offer Medication Therapy Optimization to Benefit Platform Members
DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, today announced a partnership with Philadelphia-based Beanstalk Benefits. Beanstalk Benefits is now offering the DecisionRx Medication Therapy Optimization (MTO) program to their benefit platform members to improve patient outcomes and help care teams optimize prescribing decisions for each patient.
Imperium Health Partners With DecisionRx to Deliver No-Cost Medication Therapy Optimization to Medicare Beneficiaries Enrolled in its Accountable Care Organizations
DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping physicians eliminate medication failure, today announced a partnership with Imperium Health, an innovator and pioneer in creating, organizing, and managing Accountable Care Organizations (ACO) and other value-based care programs. Imperium Health is using DecisionRx’s pharmacogenomics-driven Medication Therapy Optimization (MTO) platform to improve outcomes and reduce healthcare costs by helping physicians optimize prescribing decisions in their ACOs.
DecisionRx Announces $100 Million Credit Facility with Carlyle
DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping physicians eliminate medication failure, today announced that it has entered into a $100 million credit facility with global investment firm Carlyle.
